ALEC
HEALTHCAREAlector Inc
$2.57+0.00 (+0.00%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ALEC Today?
No stock-specific AI insight has been generated for ALEC yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.01$3.40
$2.57
Fundamentals
Market Cap$285M
P/E Ratio—
EPS$-1.39
Dividend Yield—
Dividend / Share—
ROE-1.8%
Profit Margin—
Debt / Equity—
Trading
Volume471K
Avg Volume (10D)—
Shares Outstanding111.0M
ALEC News
21 articles- Alector (ALEC) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 7, 2026
- Alector Reports First Quarter 2026 Financial Results and Provides Business UpdateYahoo Finance·May 7, 2026
- Will Alector (ALEC) Report Negative Q1 Earnings? What You Should KnowYahoo Finance·May 7, 2026
- Alkermes (ALKS) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 5, 2026
- GSK Juggles Alzheimer’s Setback And Leadership Shift With Product ProgressYahoo Finance·May 3, 2026
- How The Alector (ALEC) Narrative Is Shifting Toward BBB Shuttle Programs And Execution RiskYahoo Finance·Apr 30, 2026
- Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility AnalysisYahoo Finance·Apr 29, 2026
- Discovering Middle East's Undiscovered Gems This April 2026Yahoo Finance·Apr 28, 2026
- Dementia Market Insight, Epidemiology, and Forecasts, 2022-2025 & 2026-2034GlobeNewswire Inc.·Apr 13, 2026
- Undiscovered Gems in the Middle East for March 2026Yahoo Finance·Mar 26, 2026
- Why The Narrative Around Alector (ALEC) Is Shifting With Its BBB Shuttle FocusYahoo Finance·Mar 20, 2026
- Wall Street Turns Bullish on HIMS, TDOC and ALEC as Partnerships Reshape Risk Profiles247 Wall St·Mar 10, 2026
- Alector (ALEC)'s Technical Outlook is Bright After Key Golden CrossYahoo Finance·Mar 10, 2026
- How The Alector (ALEC) Story Is Shifting As Analyst Targets And Sector Views EvolveYahoo Finance·Mar 4, 2026
- Alector Showcases ABC Brain-Delivery Platform, AL137 and AL050 Updates at TD Cowen ConferenceMarketbeat·Mar 4, 2026
- Alector (ALEC) Reports Q4 Loss, Beats Revenue EstimatesYahoo Finance·Feb 26, 2026
- Alector: Q4 Earnings SnapshotYahoo Finance·Feb 25, 2026
- Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateYahoo Finance·Feb 25, 2026
- Alector to Participate in the TD Cowen 46th Annual Health Care ConferenceYahoo Finance·Feb 24, 2026
- What The New Sector Driven Price Target Means For Alector's Story And ValuationYahoo Finance·Feb 18, 2026
- VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Lags Revenue EstimatesYahoo Finance·Feb 12, 2026
All 21 articles loaded
Price Data
Open$2.58
Previous Close$2.57
Day High$2.70
Day Low$2.57
52 Week High$3.40
52 Week Low$1.01
52-Week Range
$1.01$3.40
$2.57
Fundamentals
Market Cap$285M
P/E Ratio—
EPS$-1.39
Dividend Yield—
Dividend / Share—
ROE-1.8%
Profit Margin—
Debt / Equity—
Trading
Volume471K
Avg Volume (10D)—
Shares Outstanding111.0M
About Alector Inc
Alector, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of neurodegenerative diseases. The company is headquartered in South San Francisco, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—